CRVS Corvus Pharmaceuticals, Inc.
Executive Summary
An institutional cluster formed in CRVS during 2025-Q3, with five institutions — including State Street, Fidelity, and Wellington — adding positions totaling $6.7M in net buying, while only Morgan Stanley trimmed its position. The buying is heavily concentrated in mega-passive funds, suggesting the cluster likely reflects index rebalancing or passive inflows rather than an active fundamental thesis, and historical model reads on CRVS have been severely negative (0% win rate at T+20, -19% avg return).
Key Financial Metrics
Institutional Positions
Net institutional flow: $6.7M
▲ Buyers (5)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| State Street | ADD | +51.4% | $7.4M | $4.8M |
| Fidelity | DOUBLED | +529.1% | $11.0K | $10.0K |
| Wells Fargo | ADD | +34.4% | $268.0K | $160.0K |
| UBS | ADD | +80.7% | $1.2M | $836.0K |
| Wellington Management Group | ADD | +76% | $1.3M | $919.0K |
▼ Sellers (1)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | TRIM | -31% | $3.6M | $971.0K |
Actionable Insight
This cluster is dominated by passive-index rebalancing (4 of 5 buyers are mega-passive), not active fundamental conviction — treat the signal as low conviction. With 92% analyst buy-rating but no active-hedge-fund buyers and historical T+20 calls on CRVS averaging -19% returns, the cluster alone does not warrant position entry. Wait for a catalyst-linked active buyer or an actionable catalyst filing before acting.
Key Facts
- 5 institutional buyers added a net $6.7M in CRVS during Q3 2025
- 4 of 5 buyers are mega-passive funds (State Street, Fidelity, Wells Fargo, UBS); only Wellington is an active asset manager
- State Street alone added $4.8M, accounting for most of the net buying
- Morgan Stanley trimmed 31% of shares but raw value increased due to share price appreciation
- Historical CRVS reports show 0% win rate at T+20 across 8 settled reports, with avg return -19%
- Ticker has 92% analyst buy/strong-buy rating and $938M market cap
Financial Impact
Institutional buyers added $6.7M in new holdings while one seller trimmed $971K in value (though dollar amount rose due to price), for net institutional accumulation of approximately $5.7M.
Risk Factors
- 45-day 13F reporting lag — positions as of Sep 30, 2025 may have been fully unwound
- Passive-dominated buying → no active fundamental thesis to trade against
- Historical model reads on CRVS have 0% T+20 win rate; cluster patterns alone likely insufficient to overcome this
Market Snapshot
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-CRVS-2025-Q3 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
1d ago
|
Institutional Cluster
| $11.19 awaiting T+5 | awaiting T+5 | — | — |
|
May 14, 2026
4w ago
|
8-K
| $13.66 $13.08 | ▼ −4.21% | ▼ −3.49% | — |
|
May 7, 2026
5w ago
|
8-K
| $15.55 $13.66 | ▼ −12.19% | ▼ −13.65% | — |
|
Apr 24, 2026
7w ago
|
DEFA14A
| $15.92 $16.02 | ▲ +0.63% | ▲ +0.23% | — |
|
Apr 21, 2026
7w ago
|
Press Release
| $17.14 $15.62 | ▼ −8.87% | ▼ −9.95% | — |
|
Mar 12, 2026
13w ago
|
Press Release
| $15.32 $13.33 | ▼ −12.99% | ▼ −10.87% | — |
|
Mar 5, 2026
14w ago
|
Press Release
| $15.80 $15.32 | ▼ −3.01% | ▼ −1.48% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access